Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of VSL3 Probiotic in the Treatment of Pouchitis After Ileal Pouch-Anal Anastomosis
2007-007977-21Phase 4Unknown
- Sponsor
- Leeds Teaching Hospitals Trust
- Start
- Dec 2010
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of VSL#3 in pouchitis, sponsored by Leeds Teaching Hospitals Trust. Primary endpoints: Clinical effectiveness of VSL3 in pouchitis and Microbiological effectiveness of antibiotic and probiotic therapy. Status: unknown.
02
Drugs
VSL#3
03
Conditions
pouchitis
Beyond the preview
Go deeper on 2007-007977-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007977-21.